Glen Industries Share Price Today | Stock Price & Glen Industries Share Screener
Track the current Glen Industries share price and stock price live with TickJournal's free stock screener. Track Glen Industries market worth to gauge the company's total market size. Use the Glen Industries stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Glen Industries opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Glen Industries Share Price Chart
Track the current stock price of Glen Industries with an interactive chart. Analyse GLEN share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Glen Industries stock quote in one place.
Glen Industries Company Profile - Fundamental Screener
Screen Glen Industries company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for GLEN shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals & Biotechnology industry, and it trades under ISIN INE0UMC01019.
Company Details
Classification
Identifiers and Leadership
Glen Industries Balance Sheet Screener
Screen GLEN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹291, up from ₹214 in 2025.
Latest statistics put total assets at ₹291 and shareholder funds at ₹140, with a leverage ratio of 1.28.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
Assets |
|||||
| Total Assets | 291 | 214 | 161 | 137 | 116 |
| Current Assets | 0 | 0 | 0 | 0 | 0 |
| Fixed Assets | 109 | 108 | 81 | 73 | 55 |
Liabilities |
|||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 30 | 56 | 40 | 41 | 41 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
|||||
| Total Equity | 140 | 59 | 46 | 36 | 23 |
| Share Capital | 32 | 18 | 6 | 6 | 6 |
| Reserves & Surplus | 107 | 41 | 40 | 31 | 17 |
Glen Industries Income Statement Screener - Profit & Revenue Analysis
Screen Glen Industries income statement and profit fundamentals. Analyze GLEN quarterly results. Glen Industries reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹0 and net profit was ₹0.
In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹205 and net profit of ₹17.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|---|---|
Revenue and Expenses | ||||||
| Revenue | 0 | 205 | 171 | 145 | 120 | 97 |
| Expenses | 0 | 166 | 130 | 120 | 103 | 83 |
Operating Costs and Margins | ||||||
| EBITDA | 0 | 39 | 41 | 25 | 17 | 14 |
| Operating Profit % | 0.00% | 18.00% | 24.00% | 17.00% | 14.00% | 12.00% |
| Depreciation | 0 | 8 | 7 | 6 | 6 | 5 |
| Interest | 0 | 9 | 9 | 7 | 6 | 4 |
Profit and Earnings | ||||||
| Profit Before Tax | 0 | 22 | 24 | 11 | 3 | 5 |
| Tax | 0 | 5 | 6 | 3 | 1 | 1 |
| Net Profit | 0 | 17 | 18 | 9 | 2 | 4 |
| EPS | 0.00 | 6.86 | 10.39 | 82.42 | 0.85 | 2.09 |
Glen Industries Cash Flow Screener - Liquidity Fundamentals
Screen GLEN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹6, and net cash flow was an outflow of ₹1.
Over the same period, investing activities used ₹18 and financing activities provided ₹11.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|---|
Cash from Operations and Investing | |||||
| Operating Activities | 6 | 6 | 14 | 11 | -14 |
| Investing Activities | -18 | -35 | -13 | -15 | -22 |
Financing and Net Cash | |||||
| Financing Activities | 11 | 30 | -2 | 4 | 34 |
| Net Cash Flow | -1 | 1 | -1 | 0 | -2 |
Glen Industries Shareholding Pattern Screener
See Glen Industries shareholding pattern with promoter, FII, and DII holdings. Check Glen Industries promoter holding and ownership changes for GLEN on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 73.31%, foreign institutions 0.00%, domestic institutions 6.64% and the public 15.47%, spread across 1,118 shareholders.
The shareholder count was 1,118 in 2026-Mar, compared with 948 in 2026-Sept.
| Item | 2026-Mar | 2026-Sept | 2025-Jun | 2025-Jul | 2025-Sept | 2024-Dec |
|---|---|---|---|---|---|---|
Promoter Holding | ||||||
| Promoter Holding | 73.31% | 74.30% | 73.00% | 73.00% | 73.00% | 100.00% |
Institutional Investors | ||||||
| FII Holding | 0.00% | 0.00% | 1.83% | 1.83% | 0.22% | 0.00% |
| DII Holding | 6.64% | 6.01% | 9.93% | 9.93% | 9.06% | 0.00% |
Government, Public and Others | ||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 15.47% | 15.50% | 11.95% | 11.95% | 12.31% | 0.00% |
| Other Holding | 4.57% | 4.19% | 3.29% | 3.29% | 5.41% | 0.00% |
| Shareholder Count | 1,118 | 948 | 1,267 | 7 | 1,196 | 7 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Glen Industries. Glen Industries dividend yield can be compared with peers and other stocks in the market.
Glen Industries Stock Index Membership - Nifty & Sensex
See which indices include Glen Industries stock. Check GLEN index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Glen Industries Market Events Screener - Corporate Actions
Get Glen Industries corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Glen Industries stock events that may affect GLEN share price, along with derivatives, futures and options activity and sector gainers.
5 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 13, 2026, with a record date of November 13, 2026.
It is followed by Annual General Meeting dated August 20, 2026 and Quarterly Result Announcement dated May 27, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-11-13 | 2026-11-13 | Quarterly Result Announcement | NA | -4.85% |
| 2026-08-20 | 2026-08-20 | Annual General Meeting | NA | 54.83% |
| 2026-05-27 | 2026-05-27 | Quarterly Result Announcement | NA | 4.56% |
| 2025-11-04 | 2025-11-04 | Quarterly Result Announcement | NA | 0.95% |
| 2025-09-22 | 2025-09-22 | Annual General Meeting | NA | -5.52% |
Glen Industries Competitors Screener - Peer Stocks Comparison
Screen GLEN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 448,676 | 40.80 | 61,674 | 12.69% | 11,565 | 60.46 |
| Divis Laboratories | 295,997 | 87.70 | 11,067 | 13.95% | 2,568 | 68.76 |
| Torrent Pharmaceuticals | 177,586 | 85.00 | 13,886 | 20.34% | 2,138 | 47.23 |
| Laurus Labs | 126,325 | 89.90 | 6,868 | 22.01% | 890 | 57.04 |
| Zydus Life Science | 120,119 | 27.60 | 27,658 | 17.64% | 5,026 | 55.91 |
| Dr Reddys Laboratories | 115,854 | 41.80 | 35,059 | 3.90% | 4,158 | 71.26 |
| Cipla | 112,131 | 39.50 | 29,045 | 2.24% | 3,870 | 53.06 |
| Mankind Pharma | 107,805 | 47.90 | 14,636 | 14.85% | 1,938 | 61.37 |
| Aurobindo Pharma | 103,229 | 25.80 | 34,145 | 5.56% | 3,503 | 60.39 |
| Lupin | 89,172 | 17.30 | 29,039 | 26.75% | 5,356 | 39.39 |
Glen Industries Company Announcements - News & Reports Screener
Screen GLEN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated .
The next most recent announcements are dated November 17, 2026 and November 17, 2026.
| Date | Update | Actions |
|---|---|---|
| Announcement under Regulation 30 (LODR)-Investor Presentation | - | |
| 2026-11-17 | Board Meeting Outcome for Unaudited Financial Results For The Half Year Ended September 302026 | - |
| 2026-11-17 | Unaudited Results For The Half Year Ended September 30 2026 | - |
| 2026-11-16 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-11-16 | Regulation 32 Monitoring Agency Report | - |
| 2026-11-13 | Board Meeting Intimation for Glen Industries Ltd Has Informed BSE That The Meeting Of The Board Of Directors Of The Company Is Scheduled On 13/11/2026 Inter Alia To Consider And Approve Unaudited Standalone And Consolidated Financial Results. | - |
| 2026-10-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-10-06 | Announcement Under Regulation 30(LODR)- Business Update | - |
| 2026-10-01 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-09-28 | Closure of Trading Window | - |
| 2026-08-28 | Announcement Under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-27 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | - |
| 2026-08-25 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | - |
| 2026-08-22 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-08-21 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | - |
| 2026-08-20 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-08-20 | Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s | - |
| 2026-08-20 | Announcement under Regulation 30 (LODR)-Meeting Updates | - |
| 2026-08-20 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-08-19 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | - |
Frequently Asked Questions
How is the company valued right now?
The P/B ratio is 1.97. Market capitalisation stands at ₹250.38 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals & Biotechnology industry, so compare these ratios with its sector peers in the table above.
About This Data
Key statistics were last updated on November 21, 2026. This page covers 5 balance sheet periods, 6 income statement periods, 5 cash flow years and 6 shareholding periods. Information is provided for research and is not investment advice.